The feasibility of testing whether Fasciola hepatica is associated with increased risk of verocytotoxin producing Escherichia coli O157 from an existing study protocol

GL Hickey, PJ Diggle, TN McNeilly, SC Tongue, ME Chase-Topping, DJL Williams

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The parasite Fasciola hepatica is a major cause of economic loss to the agricultural commu-nity worldwide as a result of morbidity and mortality in livestock, including cattle. Cattle arethe principle reservoir of verocytotoxigenic Escherichia coli O157 (VTEC O157), an impor-tant cause of disease in humans. To date there has been little empirical research on theinteraction between F. hepatica and VTEC O157. It is hypothesised that F. hepatica, whichis known to suppress type 1 immune responses and induce an anti-inflammatory or regu-latory immune environment in the host, may promote colonisation of the bovine intestinewith VTEC O157. Here we assess whether it is statistically feasible to augment a prospectivestudy to quantify the prevalence of VTEC O157 in cattle in Great Britain with a pilot studyto test this hypothesis. We simulate data under the framework of a mixed-effects logisticregression model in order to calculate the power to detect an association effect size (oddsratio) of 2. In order to reduce the resources required for such a study, we exploit the factthat the test results for VTEC O157 will be known in advance of testing for F. hepatica byrestricting analysis to farms with a VTEC O157 sample prevalence of >0% and <100%.From a total of 270 farms (mean 27 cows per farm) that will be tested for VTEC O157,power of 87% can be achieved, whereby testing of F. hepatica would only be necessary foran expected 50 farms, thus considerably reducing costs. Pre-study sample size calculationsare an important part of any study design. The framework developed here is applicable tothe study of other co-infections.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under theCC BY license (http://creativecommons.org/licenses/by/4.0/).
Original languageEnglish
Pages (from-to)97 - 104
Number of pages8
JournalPreventive Veterinary Medicine
Volume119
Issue number3-4
DOIs
Publication statusFirst published - 2015

Fingerprint

Fasciola hepatica
Escherichia coli O157
Licensure
Empirical Research
Livestock
Coinfection
Sample Size
Parasites
Anti-Inflammatory Agents
Economics
Morbidity
Costs and Cost Analysis
Mortality
Farms

Bibliographical note

2094289

Keywords

  • Co-infection
  • Fasciola hepatica
  • Mixed effects model
  • Power
  • Sample size
  • Verocytotoxigenic Escherichia coli O157

Cite this

@article{a9ce224b157d48d5a851f58fe35741ba,
title = "The feasibility of testing whether Fasciola hepatica is associated with increased risk of verocytotoxin producing Escherichia coli O157 from an existing study protocol",
abstract = "The parasite Fasciola hepatica is a major cause of economic loss to the agricultural commu-nity worldwide as a result of morbidity and mortality in livestock, including cattle. Cattle arethe principle reservoir of verocytotoxigenic Escherichia coli O157 (VTEC O157), an impor-tant cause of disease in humans. To date there has been little empirical research on theinteraction between F. hepatica and VTEC O157. It is hypothesised that F. hepatica, whichis known to suppress type 1 immune responses and induce an anti-inflammatory or regu-latory immune environment in the host, may promote colonisation of the bovine intestinewith VTEC O157. Here we assess whether it is statistically feasible to augment a prospectivestudy to quantify the prevalence of VTEC O157 in cattle in Great Britain with a pilot studyto test this hypothesis. We simulate data under the framework of a mixed-effects logisticregression model in order to calculate the power to detect an association effect size (oddsratio) of 2. In order to reduce the resources required for such a study, we exploit the factthat the test results for VTEC O157 will be known in advance of testing for F. hepatica byrestricting analysis to farms with a VTEC O157 sample prevalence of >0{\%} and <100{\%}.From a total of 270 farms (mean 27 cows per farm) that will be tested for VTEC O157,power of 87{\%} can be achieved, whereby testing of F. hepatica would only be necessary foran expected 50 farms, thus considerably reducing costs. Pre-study sample size calculationsare an important part of any study design. The framework developed here is applicable tothe study of other co-infections.{\circledC} 2015 The Authors. Published by Elsevier B.V. This is an open access article under theCC BY license (http://creativecommons.org/licenses/by/4.0/).",
keywords = "Co-infection, Fasciola hepatica, Mixed effects model, Power, Sample size, Verocytotoxigenic Escherichia coli O157",
author = "GL Hickey and PJ Diggle and TN McNeilly and SC Tongue and ME Chase-Topping and DJL Williams",
note = "2094289",
year = "2015",
doi = "10.1016/j.prevetmed.2015.02.022",
language = "English",
volume = "119",
pages = "97 -- 104",
journal = "Preventive Veterinary Medicine",
issn = "0167-5877",
publisher = "Elsevier",
number = "3-4",

}

The feasibility of testing whether Fasciola hepatica is associated with increased risk of verocytotoxin producing Escherichia coli O157 from an existing study protocol. / Hickey, GL; Diggle, PJ; McNeilly, TN; Tongue, SC; Chase-Topping, ME; Williams, DJL.

In: Preventive Veterinary Medicine, Vol. 119, No. 3-4, 2015, p. 97 - 104.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The feasibility of testing whether Fasciola hepatica is associated with increased risk of verocytotoxin producing Escherichia coli O157 from an existing study protocol

AU - Hickey, GL

AU - Diggle, PJ

AU - McNeilly, TN

AU - Tongue, SC

AU - Chase-Topping, ME

AU - Williams, DJL

N1 - 2094289

PY - 2015

Y1 - 2015

N2 - The parasite Fasciola hepatica is a major cause of economic loss to the agricultural commu-nity worldwide as a result of morbidity and mortality in livestock, including cattle. Cattle arethe principle reservoir of verocytotoxigenic Escherichia coli O157 (VTEC O157), an impor-tant cause of disease in humans. To date there has been little empirical research on theinteraction between F. hepatica and VTEC O157. It is hypothesised that F. hepatica, whichis known to suppress type 1 immune responses and induce an anti-inflammatory or regu-latory immune environment in the host, may promote colonisation of the bovine intestinewith VTEC O157. Here we assess whether it is statistically feasible to augment a prospectivestudy to quantify the prevalence of VTEC O157 in cattle in Great Britain with a pilot studyto test this hypothesis. We simulate data under the framework of a mixed-effects logisticregression model in order to calculate the power to detect an association effect size (oddsratio) of 2. In order to reduce the resources required for such a study, we exploit the factthat the test results for VTEC O157 will be known in advance of testing for F. hepatica byrestricting analysis to farms with a VTEC O157 sample prevalence of >0% and <100%.From a total of 270 farms (mean 27 cows per farm) that will be tested for VTEC O157,power of 87% can be achieved, whereby testing of F. hepatica would only be necessary foran expected 50 farms, thus considerably reducing costs. Pre-study sample size calculationsare an important part of any study design. The framework developed here is applicable tothe study of other co-infections.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under theCC BY license (http://creativecommons.org/licenses/by/4.0/).

AB - The parasite Fasciola hepatica is a major cause of economic loss to the agricultural commu-nity worldwide as a result of morbidity and mortality in livestock, including cattle. Cattle arethe principle reservoir of verocytotoxigenic Escherichia coli O157 (VTEC O157), an impor-tant cause of disease in humans. To date there has been little empirical research on theinteraction between F. hepatica and VTEC O157. It is hypothesised that F. hepatica, whichis known to suppress type 1 immune responses and induce an anti-inflammatory or regu-latory immune environment in the host, may promote colonisation of the bovine intestinewith VTEC O157. Here we assess whether it is statistically feasible to augment a prospectivestudy to quantify the prevalence of VTEC O157 in cattle in Great Britain with a pilot studyto test this hypothesis. We simulate data under the framework of a mixed-effects logisticregression model in order to calculate the power to detect an association effect size (oddsratio) of 2. In order to reduce the resources required for such a study, we exploit the factthat the test results for VTEC O157 will be known in advance of testing for F. hepatica byrestricting analysis to farms with a VTEC O157 sample prevalence of >0% and <100%.From a total of 270 farms (mean 27 cows per farm) that will be tested for VTEC O157,power of 87% can be achieved, whereby testing of F. hepatica would only be necessary foran expected 50 farms, thus considerably reducing costs. Pre-study sample size calculationsare an important part of any study design. The framework developed here is applicable tothe study of other co-infections.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under theCC BY license (http://creativecommons.org/licenses/by/4.0/).

KW - Co-infection

KW - Fasciola hepatica

KW - Mixed effects model

KW - Power

KW - Sample size

KW - Verocytotoxigenic Escherichia coli O157

U2 - 10.1016/j.prevetmed.2015.02.022

DO - 10.1016/j.prevetmed.2015.02.022

M3 - Article

VL - 119

SP - 97

EP - 104

JO - Preventive Veterinary Medicine

JF - Preventive Veterinary Medicine

SN - 0167-5877

IS - 3-4

ER -